Genentech Inc Drug Patent Portfolio

Genentech Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Genentech Inc News

Roche CEO calls on Switzerland to increase funding for new medications following agreement in the US - Bilyonaryo

22 Dec, 2025

Recursion's New CEO Discusses Transforming AI-Developed Medications into Clinical Evidence

01 Dec, 2025

Pharma 4.0: The Impact of AI on the Future of the Pharmaceutical Industry - TNGlobal

28 Oct, 2025

Biogen Directed to Compensate Genentech $88.3 Million for Previous Royalties Related to Cabilly Patents

09 Oct, 2025

See More